Oncology PracticeAlternating therapy in renal cell carcinoma fails to show an advantageMay 17, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeMore early-stage cancer diagnosis since ACA implementationMay 17, 2017Lung CancerPreventive CareGenitourinary CancerBreast CancerPractice ManagementBusiness of Medicine
Oncology PracticeFDA approves avelumab for advanced urothelial carcinomaMay 9, 2017Genitourinary Cancer
Oncology PracticeNovel agent varlilumab shows activity in RCCMay 5, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeDurvalumab approved for advanced urothelial carcinomaMay 2, 2017Genitourinary CancerImmuno-oncology
The Journal of Community and Supportive OncologyLenvatinib expands its reach into renal cell carcinomaApril 17, 2017Genitourinary Cancer
The Journal of Community and Supportive OncologyParaneoplastic leukemoid reaction – poor prognostic marker in urothelial bladder carcinomaApril 17, 2017Genitourinary CancerPatient & Survivor Care
Oncology PracticeUltrasound, cystoscopy combo tops CT for asymptomatic microscopic hematuriaApril 17, 2017Genitourinary Cancer
Oncology PracticeMetformin linked with better survival in RCC patients with diabetesApril 10, 2017Renal Cell CarcinomaGenitourinary Cancer
The Journal of Community and Supportive OncologyLiquid gold: blood-based biopsies make headwayApril 1, 2017Genitourinary CancerBreast CancerPatient & Survivor Care
Oncology PracticeUnavoidable, random DNA replication errors are the most common cancer driversMarch 23, 2017Breast CancerPediatricsPatient & Survivor CareGenitourinary CancerHodgkin LymphomaMantle Cell Lymphoma
The Journal of Community and Supportive OncologyPoint of prostate cancer diagnosis experiences and needs of black men: the Florida CaPCaS studyMarch 22, 2017Genitourinary Cancer
Oncology PracticeNo benefit from adjuvant sunitinib or sorafenib for clear cell renal cancerMarch 9, 2017Renal Cell CarcinomaGenitourinary Cancer
Oncology PracticeOutcomes of neoadjuvant therapy vary by subtype in bladder cancerMarch 6, 2017Genitourinary Cancer
Oncology PracticeChemo gives no boost to ADT for patients with localized prostate cancerMarch 1, 2017Genitourinary Cancer
